# Lexenpharm (Suzhou) Limited – FDA Inspection, Jan 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/lexenpharm-suzhou-limited/5359ceca-a341-453b-9810-2a5cd8121e49
Source feed: FDA_Inspections

> FDA inspection 1227981 of Lexenpharm (Suzhou) Limited, January 16, 2024. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1227981
- Company Name: Lexenpharm (Suzhou) Limited
- Inspection Date: 2024-01-16
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1285138 - 2025-09-04](https://www.keypedia.com/records/fda_inspections/lexenpharm-suzhou-limited/5e71d880-8f61-4b52-91c6-6e47d155439a)
- [FDA Inspection 1209990 - 2023-06-20](https://www.keypedia.com/records/fda_inspections/lexenpharm-suzhou-limited/e4fcb157-18d5-42ac-a79d-3b5901a5d4b9)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/michael-a-charles/f83241f0-ae3b-4535-ac03-e790bbf666ca)

Company: https://www.keypedia.com/companies/lexenpharm-suzhou-limited/7583aa85-4a9c-4db2-ad49-6d411885ad5f

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8